W K Amery1, P T Davies, L I Caers
1Janssen Pharmaceutica N.V., Beerse, Belgium.
This study investigated if impaired drug metabolism, specifically cytochrome P450 oxidation, contributes to migraine. Researchers found no significant difference in oxidation status between migraine sufferers and controls, suggesting it may not be a key factor in migraine development.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: